These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 28962687)

  • 1. Modulating circulating sFlt1 in an animal model of preeclampsia using PAMAM nanoparticles for siRNA delivery.
    Yu J; Jia J; Guo X; Chen R; Feng L
    Placenta; 2017 Oct; 58():1-8. PubMed ID: 28962687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Predictive value of the sFlt1/PlGF ratio for the diagnosis of preeclampsia in high-risk patients].
    Husse S; Gottschlich A; Schrey S; Stepan H; Hoffmann J
    Z Geburtshilfe Neonatol; 2014 Feb; 218(1):34-41. PubMed ID: 24595913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renin-angiotensin system transgenic mouse model recapitulates pathophysiology similar to human preeclampsia with renal injury that may be mediated through VEGF.
    Denney JM; Bird C; Gendron-Fitzpatrick A; Sampene E; Bird IM; Shah DM
    Am J Physiol Renal Physiol; 2017 Mar; 312(3):F445-F455. PubMed ID: 27927648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Villous explants from preeclamptic placentas induce sFlt1 in PBMCs: An ex vivo co-culture study.
    Gonzales SK; Badell M; Cottrell H; Rimawi B; Deepak V; Sidell N; Rajakumar A
    Pregnancy Hypertens; 2018 Apr; 12():40-46. PubMed ID: 29674197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aspirin inhibits expression of sFLT1 from human cytotrophoblasts induced by hypoxia, via cyclo-oxygenase 1.
    Li C; Raikwar NS; Santillan MK; Santillan DA; Thomas CP
    Placenta; 2015 Apr; 36(4):446-53. PubMed ID: 25638730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Soluble fms-like tyrosine kinase-1 and soluble endoglin in HIV-associated preeclampsia.
    Govender N; Naicker T; Rajakumar A; Moodley J
    Eur J Obstet Gynecol Reprod Biol; 2013 Sep; 170(1):100-5. PubMed ID: 23806447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TLR9 (Toll-Like Receptor 9) Agonist Suppresses Angiogenesis by Differentially Regulating VEGFA (Vascular Endothelial Growth Factor A) and sFLT1 (Soluble Vascular Endothelial Growth Factor Receptor 1) in Preeclampsia.
    He B; Yang X; Li Y; Huang D; Xu X; Yang W; Dai Y; Zhang H; Chen Z; Cheng W
    Hypertension; 2018 Apr; 71(4):671-680. PubMed ID: 29437897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum sFlt1 concentration during preeclampsia and mid trimester blood pressure in healthy nulliparous women.
    Levine RJ; Qian C; Maynard SE; Yu KF; Epstein FH; Karumanchi SA
    Am J Obstet Gynecol; 2006 Apr; 194(4):1034-41. PubMed ID: 16580293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An analysis on the roles of angiogenesis-related factors including serum vitamin D, soluble endoglin (sEng), soluble fms-like tyrosine kinase 1 (sFlt1), and vascular endothelial growth factor (VEGF) in the diagnosis and severity of late-onset preeclampsia.
    Cim N; Kurdoglu M; Ege S; Yoruk I; Yaman G; Yildizhan R
    J Matern Fetal Neonatal Med; 2017 Jul; 30(13):1602-1607. PubMed ID: 27658884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. First-Trimester Maternal Serum Levels of sFLT1, PGF and ADMA Predict Preeclampsia.
    Bian Z; Shixia C; Duan T
    PLoS One; 2015; 10(4):e0124684. PubMed ID: 25906026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of acute lung inflammation by pulmonary delivery of anti-TNF-α siRNA with PAMAM dendrimers in a murine model.
    Bohr A; Tsapis N; Foged C; Andreana I; Yang M; Fattal E
    Eur J Pharm Biopharm; 2020 Nov; 156():114-120. PubMed ID: 32798665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiogenic factor imbalance early in pregnancy predicts adverse outcomes in patients with lupus and antiphospholipid antibodies: results of the PROMISSE study.
    Kim MY; Buyon JP; Guerra MM; Rana S; Zhang D; Laskin CA; Petri M; Lockshin MD; Sammaritano LR; Branch DW; Porter TF; Merrill JT; Stephenson MD; Gao Q; Karumanchi SA; Salmon JE
    Am J Obstet Gynecol; 2016 Jan; 214(1):108.e1-108.e14. PubMed ID: 26432463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decidual cells from women with preeclampsia exhibit inadequate decidualization and reduced sFlt1 suppression.
    Sahu MB; Deepak V; Gonzales SK; Rimawi B; Watkins KK; Smith AK; Badell ML; Sidell N; Rajakumar A
    Pregnancy Hypertens; 2019 Jan; 15():64-71. PubMed ID: 30825929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficient siRNA transfer to knockdown a placenta specific lncRNA using RGD-modified nano-liposome: A new preeclampsia-like mouse model.
    Yu Q; Qiu Y; Wang X; Tang J; Liu Y; Mei L; Li M; Yang M; Tang L; Gao H; Zhang Z; Xu W; He Q
    Int J Pharm; 2018 Jul; 546(1-2):115-124. PubMed ID: 29729405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating Angiogenic Factors and the Risk of Adverse Outcomes among Haitian Women with Preeclampsia.
    March MI; Geahchan C; Wenger J; Raghuraman N; Berg A; Haddow H; Mckeon BA; Narcisse R; David JL; Scott J; Thadhani R; Karumanchi SA; Rana S
    PLoS One; 2015; 10(5):e0126815. PubMed ID: 25965397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. KRYPTOR-automated angiogenic factor assays and risk of preeclampsia-related adverse outcomes.
    Salahuddin S; Wenger JB; Zhang D; Thadhani R; Karumanchi SA; Rana S
    Hypertens Pregnancy; 2016 Aug; 35(3):330-45. PubMed ID: 27028795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating concentrations of sFlt1 (soluble fms-like tyrosine kinase 1) in fetal and maternal serum during pre-eclampsia.
    Staff AC; Braekke K; Harsem NK; Lyberg T; Holthe MR
    Eur J Obstet Gynecol Reprod Biol; 2005 Sep; 122(1):33-9. PubMed ID: 15935542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel human-specific soluble vascular endothelial growth factor receptor 1: cell-type-specific splicing and implications to vascular endothelial growth factor homeostasis and preeclampsia.
    Sela S; Itin A; Natanson-Yaron S; Greenfield C; Goldman-Wohl D; Yagel S; Keshet E
    Circ Res; 2008 Jun; 102(12):1566-74. PubMed ID: 18515749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gestational angiogenic biomarker patterns in high risk preeclampsia groups.
    Maynard SE; Crawford SL; Bathgate S; Yan J; Robidoux L; Moore M; Moore Simas TA
    Am J Obstet Gynecol; 2013 Jul; 209(1):53.e1-9. PubMed ID: 23517919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Soluble endoglin and other circulating antiangiogenic factors in preeclampsia.
    Levine RJ; Lam C; Qian C; Yu KF; Maynard SE; Sachs BP; Sibai BM; Epstein FH; Romero R; Thadhani R; Karumanchi SA;
    N Engl J Med; 2006 Sep; 355(10):992-1005. PubMed ID: 16957146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.